These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22808296)

  • 1. Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma.
    Liu F; Karube K; Kato H; Arita K; Yoshida N; Yamamoto K; Tsuzuki S; Kim W; Ko YH; Seto M
    Int J Clin Exp Pathol; 2012; 5(5):436-41. PubMed ID: 22808296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
    Zhu D; Ikpatt OF; Dubovy SR; Lossos C; Natkunam Y; Chapman-Fredricks JR; Fan YS; Lossos IS
    Am J Hematol; 2013 Sep; 88(9):730-5. PubMed ID: 23720088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
    Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
    Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.
    Moody S; Escudero-Ibarz L; Wang M; Clipson A; Ochoa Ruiz E; Dunn-Walters D; Xue X; Zeng N; Robson A; Chuang SS; Cogliatti S; Liu H; Goodlad J; Ashton-Key M; Raderer M; Bi Y; Du MQ
    J Pathol; 2017 Sep; 243(1):3-8. PubMed ID: 28682481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
    Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
    Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
    Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A20 inactivation in ocular adnexal MALT lymphoma.
    Bi Y; Zeng N; Chanudet E; Huang Y; Hamoudi RA; Liu H; Dong G; Watkins AJ; Ley SC; Zou L; Chen R; Zhu X; Du MQ
    Haematologica; 2012 Jun; 97(6):926-30. PubMed ID: 22207688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
    Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
    Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
    Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.
    Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.
    Johansson P; Klein-Hitpass L; Grabellus F; Arnold G; Klapper W; Pförtner R; Dührsen U; Eckstein A; Dürig J; Küppers R
    Oncotarget; 2016 Sep; 7(38):62627-62639. PubMed ID: 27566587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
    Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
    Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct involvement of NF-κB regulators by somatic mutation in ocular adnexal malt lymphoma.
    Yan Q; Wang M; Moody S; Xue X; Huang Y; Bi Y; Du MQ
    Br J Haematol; 2013 Mar; 160(6):851-4. PubMed ID: 23240725
    [No Abstract]   [Full Text] [Related]  

  • 15. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
    Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ
    J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
    Reimann M; Schrezenmeier J; Richter-Pechanska P; Dolnik A; Hick TP; Schleich K; Cai X; Fan DNY; Lohneis P; Maßwig S; Denker S; Busse A; Knittel G; Flümann R; Childs D; Childs L; Gätjens-Sanchez AM; Bullinger L; Rosenwald A; Reinhardt HC; Schmitt CA
    Blood; 2021 May; 137(20):2785-2799. PubMed ID: 33232972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.
    Philipp C; Edelmann J; Bühler A; Winkler D; Stilgenbauer S; Küppers R
    Int J Cancer; 2011 Apr; 128(7):1747-50. PubMed ID: 20533286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
    Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma.
    Dong G; Chanudet E; Zeng N; Appert A; Chen YW; Au WY; Hamoudi RA; Watkins AJ; Ye H; Liu H; Gao Z; Chuang SS; Srivastava G; Du MQ
    Clin Cancer Res; 2011 Mar; 17(6):1440-51. PubMed ID: 21266526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
    Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
    Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.